Tamoxifen Has Been Shown To Slow the Growth of Tumours That Are Oestrogen Receptor Positive (ER+)12/29/2022 Tamoxifen is a female hormone antagonist and so it fights the breast cancer cells by depleting estrogen supply. It has been used to treat uterine, ovarian and fallopian tubal cancer. Tamoxifen is a drug that is used to treat breast cancer. Tamoxifen has been found to slow the growth of estrogen receptor positive (ER+) tumors in the breast, but does not affect ER negative (ER-) tumor cells.
TAMIFLU is a prescription medication used to treat women who are going through menopause. It is not intended for use during pregnancy or while breast-feeding. Tamoxifen works by blocking the effect of estrogen on breast cancer cells, which may slow down or prevent tumor growth in the body. Tamoxifen, used by women with estrogen receptor-positive breast cancer, has a strong adverse effect on systemic blood pressure. Tamoxifen leads to no significant change in dietary intake, as measured by food diaries or 3-day food records. Its safety is supported by prior clinical experience and was also seen at doses of 20 mg daily that are considered effective by the FDA. Read More: http://versatileblogger.weebly.com/article/tamoxifen-has-been-connected-to-birth-defects
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2023
Categories |